-
Vaccine demonstrates efficacy against mutated polio strain in Phase II study
europeanpharmaceuticalreview
December 15, 2020
A clinical trial has shown that nOPV2 has the potential to overcome outbreaks caused by a mutated polio strain linked to the Sabin vaccine.
-
Rich countries buy up majority of COVID-19 vaccine doses, People’s Vaccine Alliance says
europeanpharmaceuticalreview
December 11, 2020
According to the alliance, 70 poor countries will only be able to vaccinate one in 10 people against COVID-19 next year after rich countries bought up most prophylactics.
-
A large basket of COVID-19 vaccine candidates is important: Renu Swarup
expresspharma
December 07, 2020
She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and challenges.
-
KU Leuven vaccine candidate protects against COVID-19 and yellow fever
worldpharmanews
December 04, 2020
Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against COVID-19 based on the yellow fever vaccine, which as a result also works against yellow fever.
-
Pharmacists Ready to Receive and Administer COVID-19 Vaccines, According to APhA Survey
prnewswire
December 03, 2020
More than three quarters of pharmacists plan to be vaccinated with one of the COVID vaccines, and 60% will be set up and ready to vaccinate patients as soon as the vaccine is available, in a recent nationwide survey of 400 pharmacists conducted by the ...
-
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma
expresspharma
December 01, 2020
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including COVID-19.
-
Moderna announces vaccine efficacy of 94.1 per cent, to file for EUA with US FDA
expresspharma
December 01, 2020
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe.
-
Russia to vaccinate armed forces against COVID-19 as new cases hit daily record
expresspharma
November 30, 2020
Russia plans to vaccinate more than 400,000 military personnel against COVID-19, Defence Minister Sergei Shoigu said on Friday, as authorities reported a record 27,543 new coronavirus cases.
-
The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets
prnasia
November 26, 2020
The Russian Direct Investment Fund announces the cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is less than $20 for the two doses necessary to vaccinate one person.
-
Governments should work as a team for smooth, sustained COVID-19 vaccination drive: PM Modi
expresspharma
November 25, 2020
The PM said that any vaccine against coronavirus that is administered to citizens will meet all necessary scientific criteria.